Top Markets
Coin of the day
Bioptik Technology Incorporation Bioptik Technology Incorporation

Bioptik Technology Incorporation

4161
Rankning i aktier #26078
Bioptik Technology Incorporation operates as a global entity, focusing on the... Bioptik Technology Incorporation operates as a global entity, focusing on the creation and distribution of medical instruments and diagnostic chemicals. The company's product line encompasses the EasyMate series of blood glucose monitoring systems, as well as comprehensive diagnostic devices designed to measure blood glucose, cholesterol, and uric acid levels, complete with their essential test strips. Beyond its healthcare offerings, Bioptik also provides a range of skincare solutions, including those formulated with hyaluronic acid, alongside various dietary supplements. Uniquely, the company diversifies its business by supplying biodiesel products. Founded in 1999, Bioptik Technology Incorporation is headquartered in Zhunan, Taiwan.
Aktiekurs
$0.72978769
Marknadsvärde
$43.65M
Förändring (1 dag)
1.10%
Förändring (1 år)
-17.81%
Land
TW
Handel Bioptik Technology Incorporation (4161)

Kategori

Utdelningsavkastning för Bioptik Technology Incorporation (4161)
Utdelningsavkastningen (TTM) för Bioptik Technology Incorporation (aktiesymbol: 4161) per 2026 är: 0
Genomsnittlig utdelningsavkastning de senaste 5 åren: 0.00%
Historik för utdelningsavkastning för Bioptik Technology Incorporation (4161) från 2026 till 2026
Utdelningsavkastning i slutet av varje år (TTM)
År Utdelningsavkastning Ändra
Inte tillräckligt med data för de angivna datumen.
Utdelningsavkastning (TTM) för liknande företag eller konkurrenter